ZimVie — Q2 2023 Earnings Presentation
11 slides from ZimVie's earnings presentation, Aug 2, 2023
Slide 1: Supplemental Financial Information
Supplemental Financial Information August 2, 2023 Exhibit 99.2
Slide 2: Forward-Looking Statements and Non-GAAP Measures
FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation contains forward-looking statements within the meaning of federal securities laws, including, among others, any statements about our expectations, plans
Slide 3: 2Q 2023 Results
2Q 2023 Results 13.2% Adjusted EBITDA Margin[1] $0.17 Adjusted Diluted EPS[1] Third Party Net Sales: $224.9M Adjusted EBITDA[1]: $29.7M Adjusted Net Income[1]: $4.3M [1] This is a Non-GAAP financial measure. Refer to the reconciliation in the Appendix for further information. $118.7M in Dental Third
Slide 4: 2023 Full-Year Financial Guidance
2023 Full-Year Financial Guidance Line Item 2023 Guidance Net Sales* $850M - $870M Gross Margin[1] Mid-to-High 60%s Adjusted EBITDA Margin[1] 13.5% - 14.0% Interest Expense $37M - $39M Stock-Based Compensation[1][2] $16.5M - $19.5M Adjusted Effective Tax Rate[1] 26.0% Fully Diluted Shares Outstandin
Slide 5: Appendix
Bendix 2 ZimVie
Slide 6: Note on Non-GAAP Financial Measures
Note on Non-GAAP Financial Measures This presentation includes non-GAAP financial measures that differ from financial measures calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These non-GAAP financial measures may not be comparable to similar measures reported by
Slide 7: Net Sales by Region and Segment
ZimVie NET SALES BY REGION AND SEGMENT (in thousands)
Slide 8: EBITDA
ZimVie RECONCILIATION OF ADJUSTED EBITDA (in thousands) [1] In April 2023, we instituted restructuring activities to better position our organization for future success based on the current business environment, and the expenses incurred under this plan were primarily related to severance and profes
Slide 9: Gross Profit and Margin
ZimVie RECONCILIATION OF ADJUSTED GROSS PROFIT AND MARGIN (in thousands) [1] The 2022 amounts represent one-time expenses captured through allocations made for purposes of the GAAP carve-out financial statement results. The 2023 amounts represent non-cash step-up amortization related to the separati
Slide 10: R&D and SG&A
ZimVie RECONCILIATION OF ADJUSTED R&D AND SG&A (in thousands) [1] Expenses incurred for initial compliance with the European Union Medical Device Regulation for previously-approved products. [2] One-time share-based compensation expense due to replacement awards provided in connection with the separ
Slide 11: Net Income (Loss) and Adjusted EPS
ZimVie RECONCILIATION OF ADJUSTED NET INCOME (LOSS) AND ADJUSTED EPS (in thousands, except per share data) [1] In April 2023, we instituted restructuring activities to better position our organization for future success based on the current business environment, and the expenses incurred under this